MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.

MLA

Zhu, Ziqiang, et al. “MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.” PloS One, vol. 11, no. 3, Mar. 2016, p. e0150026. EBSCOhost, https://doi.org/10.1371/journal.pone.0150026.

APA

Zhu, Z., Tang, J., Wang, J., Duan, G., Zhou, L., & Zhou, X. (2016). MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells. PloS One, 11(3), e0150026. https://doi.org/10.1371/journal.pone.0150026

Chicago

Zhu, Ziqiang, Jinshan Tang, Jianqiang Wang, Gang Duan, Lei Zhou, and Xiaoqing Zhou. 2016. “MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.” PloS One 11 (3): e0150026. doi:10.1371/journal.pone.0150026.